Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-002838
Filing Date
2022-03-10
Accepted
2022-03-10 17:00:22
Documents
1
Period of Report
2022-03-09

Document Format Files

Seq Description Document Type Size
1 form4-03102022_050302.html 4  
1 form4-03102022_050302.xml 4 3683
  Complete submission text file 0001415889-22-002838.txt   4987
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Issuer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XENCOR, INC. 111 WEST LEMON AVENUE MONROVIA CA 91016
Business Address
Dahiyat Bassil I (Reporting) CIK: 0001591312 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36182 | Film No.: 22729855